Photos: Novo Nordisk Improved FlexPen(R) Now Available i...(ou take NovoLog(R) Mix 70/30. Do ...),Health

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Never mix NovoLog(R) Mix 70/30 with other insulin products or use it in an insulin pump.

Do not use NovoLog(R) Mix 70/30 if your blood glucose is too low (hypoglycemia) or if you are allergic to anything in NovoLog(R) Mix 70/30. If you take too much NovoLog(R) Mix 70/30 your blood sugar may fall too low.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog(R) Mix 70/30 dose may change if you take other medicines.

The most common side effect of insulin therapy, including NovoLog(R) Mix 70/30, is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

*Lantus SoloStar(R) is a disposable insulin delivery device developed, manufactured and marketed by sanofi-aventis.

Lantus(R), SoloSTAR(R) is a registered trademark of sanofi-aventis U.S., LLC. FlexPen(R), Levemir(R), and NovoLog(R) are registered trademarks of Novo Nordisk A/S.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nord
'/>"/>